Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
St. Louis University
Summary
A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).
Description
A retrospective registry of stenting plus medical management for the prevention of recurrent stroke in patients with symptomatic Vertebral Artery origin Stenosis (VAOS). This study is collecting information on clinical outcomes up to 18 months post-treatment. On January 6, 2025, VOTER was changed from prospective to retrospective.
Eligibility
- Age range
- 18–90 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Patients between 18 and 90 years of age 2. Patient has experienced a posterior circulation ischemic event 3. Patient has angiographically confirmed bilateral vertebral artery origin disease (Hypoplasia, occlusion, or stenosis). 4. Patient has \>50% stenosis on the side being targeted for therapy Exclusion Criteria: 1. Pregnant women 2. Contrast Indication to the use of anti-platelet drugs 3. There is tandem vertebral or basilar artery stenosis 4. The serum creatinin is \>2.5 5. Baseline modified Rankin score is \>3 6. \< 5 years life expectancy
Interventions
- OtherObservational Prospective Registry
This is a prospective registry looking at patients admitted for stroke with evidence of Vertebral Artery Origin Stenosis. Patients clinical outcomes will be collected at 30 days and 1-year post-treatment and angiographic outcomes at 1-year post-treatment
Locations (10)
- Baptist Medical Center JacksonvilleJacksonville, Florida
- University of Southern FloridaTampa, Florida
- Northwestern Medicine Regional Medical GroupWinfield, Illinois
- University of IowaIowa City, Iowa
- SSM DePaul HospitalBridgeton, Missouri
- Saint Louis UniversitySt Louis, Missouri